Owen A Ross Selected Research

Apolipoprotein E4

10/2023	Genome-wide association study identifies APOE and ZMIZ1 variants as mitophagy modifiers in Lewy body disease.
1/2023	APOE2 Exacerbates TDP-43 Related Toxicity in the Absence of Alzheimer Pathology.
1/2022	APOE4 exacerbates α-synuclein seeding activity and contributes to neurotoxicity in Alzheimer's disease with Lewy body pathology.
1/2020	APOE4 exacerbates α-synuclein pathology and related toxicity independent of amyloid.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Owen A Ross Research Topics

Disease

76	Parkinson Disease (Parkinson's Disease) 01/2024 - 09/2002
34	Parkinsonian Disorders (Parkinsonism) 01/2023 - 04/2005
23	Alzheimer Disease (Alzheimer's Disease) 12/2023 - 03/2007
19	Dementia (Dementias) 11/2023 - 05/2007
17	Lewy Body Disease (Lewy Body Dementia) 10/2023 - 07/2009
12	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2023 - 05/2007
11	Multiple System Atrophy 01/2023 - 08/2007
9	Synucleinopathies 01/2024 - 01/2014
8	Essential Tremor (Essential Tremors) 12/2016 - 09/2009
7	Tauopathies 05/2024 - 10/2014
7	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 12/2023 - 03/2007
7	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 07/2023 - 05/2007
7	Tremor (Tremors) 01/2022 - 04/2010
6	Cognitive Dysfunction 02/2024 - 11/2009
6	Ischemic Stroke 10/2022 - 01/2013
5	Dyskinesias (Dyskinesia) 09/2023 - 04/2010
5	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2023 - 08/2011
5	Dystonia (Limb Dystonia) 01/2022 - 05/2007
5	Stroke (Strokes) 03/2021 - 05/2010
4	Genetic Risk Score 02/2024 - 01/2022
4	Frontotemporal Dementia (Semantic Dementia) 07/2023 - 08/2012
4	Atrophy 10/2022 - 03/2014
4	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2021 - 03/2014
4	Corticobasal Degeneration 12/2020 - 08/2012
4	Mitochondrial Diseases (Mitochondrial Disease) 11/2014 - 04/2003
3	Gliosis 01/2023 - 08/2019
2	Pick Disease of the Brain (Pick's Disease) 05/2024 - 01/2021
2	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 11/2023 - 05/2015
2	Amyloidosis 11/2023 - 01/2021
2	Brain Diseases (Brain Disorder) 10/2023 - 11/2009
2	Neoplasms (Cancer) 01/2023 - 01/2018
2	Disease Progression 01/2022 - 01/2022
2	Transient Ischemic Attack 03/2021 - 01/2020
2	Movement Disorders (Movement Disorder) 01/2021 - 10/2016
2	Disease Susceptibility (Diathesis) 01/2021 - 10/2013
2	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 01/2021 - 08/2011
2	Proteostasis Deficiencies 01/2019 - 10/2014
2	REM Sleep Behavior Disorder 07/2017 - 08/2016
1	Vascular Diseases (Vascular Disease) 03/2024
1	Macular Degeneration (Age-Related Maculopathy) 12/2023
1	Neurobehavioral Manifestations 10/2023
1	Amyloid Plaque 07/2023
1	Memory Disorders (Memory Loss) 07/2023
1	TDP-43 Proteinopathies 01/2023
1	Motor Neuron Disease (Primary Lateral Sclerosis) 01/2023
1	Neoplasm Metastasis (Metastasis) 01/2023
1	Venous Thrombosis (Deep-Vein Thrombosis) 10/2022
1	Striatonigral Degeneration 10/2022
1	Autonomic Nervous System Diseases (Dysautonomia) 10/2022
1	Cerebellar Ataxia (Dysmetria) 10/2022

Drug/Important Bio-Agent (IBA)

22	SynucleinsIBA 10/2023 - 08/2010
21	Phosphotransferases (Kinase)IBA 01/2021 - 04/2005
18	Leucine (L-Leucine)FDA Link 01/2021 - 04/2005
17	Apolipoproteins E (ApoE)IBA 02/2024 - 03/2007
15	Proteins (Proteins, Gene)FDA Link 01/2023 - 09/2005
14	Amyloid (Amyloid Fibrils)IBA 03/2024 - 05/2015
12	Biomarkers (Surrogate Marker)IBA 11/2023 - 11/2009
12	alpha-SynucleinIBA 01/2023 - 09/2002
11	Levodopa (L Dopa)FDA LinkGeneric 09/2023 - 11/2009
11	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 12/2020 - 05/2011
7	Mitochondrial DNA (mtDNA)IBA 01/2022 - 04/2003
6	Glucosylceramidase (Glucocerebrosidase)IBA 01/2020 - 06/2010
5	UbiquitinIBA 03/2024 - 05/2007
5	ApolipoproteinsIBA 01/2022 - 03/2014
4	tau Proteins (tau Protein)IBA 05/2024 - 08/2015
4	DNA-Binding Proteins (DNA Binding Protein)IBA 11/2023 - 01/2018
4	Apolipoprotein E4IBA 10/2023 - 01/2020
4	EnzymesIBA 01/2023 - 11/2011
3	Apolipoprotein E3IBA 01/2023 - 01/2020
3	NucleotidesIBA 01/2021 - 01/2019
3	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 07/2009
2	Protein Isoforms (Isoforms)IBA 05/2024 - 04/2023
2	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 03/2024 - 11/2017
2	Dopamine (Intropin)FDA LinkGeneric 09/2023 - 01/2016
2	Carbonyl Cyanide m-Chlorophenyl Hydrazone (CCCP)IBA 01/2023 - 01/2018
2	Apolipoprotein E2IBA 01/2023 - 01/2020
2	HLA Antigens (Human Leukocyte Antigens)IBA 01/2023 - 06/2011
2	ImmunosorbentsIBA 01/2023 - 01/2023
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 03/2021 - 01/2020
2	Serine (L-Serine)FDA Link 01/2021 - 01/2018
2	CytokinesIBA 01/2018 - 09/2007
2	PTEN-induced putative kinaseIBA 01/2017 - 11/2014
2	Glutamic Acid (Glutamate)FDA Link 01/2016 - 06/2014
2	levodopa drug combination carbidopa (Nakom)FDA LinkGeneric 01/2016 - 01/2016
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 08/2015 - 05/2011
2	Amino Acids FDA Link 08/2015 - 01/2013
2	GTP Cyclohydrolase (GTP Cyclohydrolase I)IBA 03/2014 - 10/2009
2	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2014 - 01/2014
2	Leucine-Rich Repeat Serine-Threonine Protein Kinase-2IBA 07/2009 - 10/2007
1	ORALIT (ORS)IBA 05/2024
1	N-(4-aminophenethyl)spiroperidol (NAPS)IBA 01/2024
1	Valosin Containing ProteinIBA 01/2024
1	thioflavin TIBA 07/2023
1	Adenosine Triphosphate (ATP)IBA 01/2023
1	Complement System Proteins (Complement)IBA 10/2022
1	Blood Group Antigens (Blood Groups)IBA 10/2022
1	AutoantibodiesIBA 10/2022

Therapy/Procedure

11	Therapeutics 05/2024 - 01/2016
2	Precision Medicine 10/2023 - 01/2022
1	Radiotherapy 01/2023